Table 5. Risk factors affecting recurrence-free and overall survival.
Recurrence-free survival | ||||||
---|---|---|---|---|---|---|
Variable | Univariate analysis | Multivariate analysis* | ||||
HR | 95% CI | p-value | HR | 95% CI | p-value | |
PD-L1 immunoreactivity (positive vs. negative) | 3.125 | 1.448 - 6.745 | 0.0037 | 3.029 | 1.228 - 7.471 | 0.0018 |
Lymph node involvement (present vs. absent) | 3.076 | 1.546 - 6.119 | 0.0014 | 3.012 | 1.508 - 6.018 | 0.016 |
Overall survival | ||||||
Variable | Univariate analysis | Multivariate analysis* | ||||
HR | 95% CI | p-value | HR | 95% CI | p-value | |
PD-L1 immunoreactivity (positive vs. negative) | 2.222 | 0.928 - 5.32 | 0.07 | |||
Lymph node involvement (present vs. absent) | 5.038 | 2.28 - 11.13 | 0.00006 |
CI, confidence interval; HR, Hazard ratio.
*Only variables significantly associated in the univariate analysis were included in the multivariate analysis.